Skip to content

Clinical trials

Phase 2 Dermatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Phase: Phase 2 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20093
20111
20121
20141
20161
20183
20191
20205
20213
20223
20233
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting5
Recruiting5
Withdrawn3
Unknown status2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Aclaris Therapeutics, Inc.2
Apollo Therapeutics Ltd2
Forte Biosciences, Inc.2
GlaxoSmithKline2
Inmagene LLC2
University of Minnesota2
AbbVie1
Allakos Inc.1
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis40
Dermatitis, Atopic26
Eczema23
Skin Diseases16
Immune System Diseases8
Pruritus5
Skin Diseases, Eczematous5
Skin Diseases, Genetic3
Breast Neoplasms2
Hidradenitis Suppurativa2

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.